1887

Cabergoline

This is a drug monograph from the BSAVA Small Animal Formulary Part B: Exotic Pets. BSAVA members should login for access to the full monograph. Non-members can join BSAVA, buy a Formulary subscription, or buy the printed edition.
  1. Beltrame D, Longo M and Mazué G (1996) Reproductive toxicity of cabergoline in mice, rats and rabbits. Reproductive Toxicology 10(6), 471–483
  2. Eguchi K, Kawamoto K, Uozumi T et al. (1995) Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: In vitro culture studies. Endocrine Journal 42(3), 413–420
  3. Mayer J, Sato A, Kiupel M, DeCubellis J and Donnelly T (2011) Extralabel use of cabergoline in the treatment of a pituitary adenoma in a rat. Journal of the American Veterinary Medical Association 239(5), 656–660
  4. Chitty J, Raftery A and Lawrie A (2006) Use of cabergoline in companion psittacine birds. Proceedings of the Association of Avian Veterinarians pp. 65–57
  5. Rückl A, Thompson Jr DL and Hatt JM (2022) Effect of the prolactin inhibitor cabergoline and the gonadotropin releasing-hormone agonist deslorelin in the suppression of plasma prolactin concentrations and egg laying in quail (Coturnix japonica). Journal of Avian Medicine and Surgery 36(1), 39–52
  6. Smiley KO and Adkins-Regan E (2016) Prolactin is related to individual differences in parental behavior and reproductive success in a biparental passerine, the zebra finch (Taeniopygia guttata). General and Comparative Endocrinology 234, 88–94
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error